MedPath

Impact of Atelectasis on RVEDP Following Orthotropic Heart Transplantation

Recruiting
Conditions
Heart Transplant Failure
Anesthesia
Interventions
Other: Lung Recruitment
Registration Number
NCT06140810
Lead Sponsor
Baylor College of Medicine
Brief Summary

Following orthoptopic heart transplantation (OHT), children undergo surveillance cardiac catheterizations to assess for signs of rejection including muscle biopsy as well as pressure measurements to guide post transplant treatment regiments. These procedures are done under general anesthesia which promotes lung tissue collapse (atelectasis). What is not known is the effect of atelectasis on intracardiac pressures which are a critical area of monitoring post-transplant patients for rejection.

Detailed Description

Following orthoptopic heart transplantation (OHT), children undergo surveillance cardiac catheterizations to assess for signs of rejection including muscle biopsy as well as pressure measurements. These procedures are done under general anesthesia which promotes lung tissue collapse (atelectasis). Atalectaisis is known to alter intra-thoracic pressures and cardiac loading conditions. What is not known is the effect of atelectasis on intracardiac pressures which are a critical area of monitoring post-transplant patients for rejection. Therefore, the aim of this study is to identify if atelectasis impacts the pressure measurements obtained during cardiac catheterization.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
15
Inclusion Criteria
  • Patients having undergone orthotropic heart transplantation
  • Patients requiring routine heart catheterization for post-transplant surveillance
  • General anesthesia
Exclusion Criteria
  • Patient/parental refusal
  • Patients with suspected or known acute rejection
  • Known anti-rejection medication non-compliance
  • Patients within 1 year following heart transplant
  • Home oxygen requirement
  • Previous lung surgery (e.g., lobectomy) other than biopsy
  • Lung transplantation
  • Known pulmonary fibrosis
  • Known pulmonary hypertension (>1/2 systemic)
  • Sedation without the use of an airway device
  • Active respiratory infection -Inability to provide recruitment breaths >25mmHg -Cardiomegaly
  • Recipient/donor size mismatch

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Right ventricular End diastolic pressureLung RecruitmentMeasurement of pre and post recruitment right ventricular end diastolic pressure
Primary Outcome Measures
NameTimeMethod
Number of participants with reduction of right ventricular end diastolic pressure of 3mmHg or greater10 minutes

Change of the right ventricular end diastolic pressure from pre and post recruitment breaths

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Texas Childrens Hospital

🇺🇸

Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath